학술논문

Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma
Document Type
Correspondence
Source
In Blood Advances 28 February 2023 7(4):644-648
Subject
Immunobiology and Immunotherapy
Clinical Trials and Observations
Lymphoid Neoplasia
Language
ISSN
2473-9529